US EditionSpanish Scientists Manage to Block the Molecule that Causes Relapses and Metastasis in More Aggressive Breast Cancer
9 Articles
9 Articles
"The big problem with cancer is often the spread of disease," explains researcher Fernando Lecanda. When a cancer is localized, survival rates are high, but when tumor cells have escaped and form other tumors in other organs, the survival rate is worse.
A study developed by scientists at the Cancer Center Clínica Universidad de Navarra (CCUN) in preclinical models has shown that the pharmacological blockade of...
Researchers at the University of Navarra have shown that the pharmacological blockade of the ENPP1 molecule enhances the efficacy of radiation therapy.
A group of Spanish scientists have conducted a study in which a therapy has been discovered that prevents the relapse of triple negative breast cancer and the spread of tumor cells. This therapy is designed by the Cancer Center Clínica Universidad de Navarra (CCUN).
A study conducted in preclinical models has shown that the pharmacological block of the ENPP1 molecule enhances the effectiveness of radiation therapy and manages to eradicate the relapse of triple negative breast cancer – the most aggressive for patients – as well as the spread of tumor cells to other organs. The work has been developed by scientists at the Cancer Center Clínica Universidad de Navarra (CCUN) and published in Signal Transduction…
A study by scientists at the Cancer Center Clínica Universidad de Navarra (CCUN) in preclinical models has shown that the pharmacological block of the ENPP1 molecule enhances the effectiveness of radiation therapy and manages to eradicate the relapse of triple negative breast cancer – the most aggressive for patients – as well as the spread of tumor cells to other organs.
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
